The UK NHS will offer Efa (Altuviiio in US, Altuvoct in Europe) for the treatment of #hemophilia A. To call it a miracle drug when we have so many treatments already is a tad much. I also do not believe the NHS will pay £510,000 per year. This is 5x the cost of emicizumab. tinyurl.com/mr2xym3t
Miracle drug costing £510k per year to be offered on NHS for incurable disease
The weekly injection could be life-changing for sufferers.
tinyurl.com
February 28, 2025 at 8:46 PM
The UK NHS will offer Efa (Altuviiio in US, Altuvoct in Europe) for the treatment of #hemophilia A. To call it a miracle drug when we have so many treatments already is a tad much. I also do not believe the NHS will pay £510,000 per year. This is 5x the cost of emicizumab. tinyurl.com/mr2xym3t
Explore the journey to a once-weekly treatment for people with hemophilia A and their outcomes through a review of real-world patient cases in this week's NBDF Wednesday Webinar, sponsored by Sanofi.
Sept 30, 2PM ET
bleeding.org/events
#RealWorldData
#Hemophilia
#Altuviiio
Sept 30, 2PM ET
bleeding.org/events
#RealWorldData
#Hemophilia
#Altuviiio
Upcoming Events for the Bleeding Disorders Community | NBDF
Discover in-person and virtual events to connect with the bleeding disorders community. Stay informed about upcoming gatherings, workshops, and conferences.
bleeding.org
September 28, 2026 at 1:43 PM
Explore the journey to a once-weekly treatment for people with hemophilia A and their outcomes through a review of real-world patient cases in this week's NBDF Wednesday Webinar, sponsored by Sanofi.
Sept 30, 2PM ET
bleeding.org/events
#RealWorldData
#Hemophilia
#Altuviiio
Sept 30, 2PM ET
bleeding.org/events
#RealWorldData
#Hemophilia
#Altuviiio
Sanofi’s #ASH25 data highlight leadership in rare blood diseases, from multi-immune modulation with #BTKinhibitor Wayrilz to long-term hemophilia care with ALTUVIIIO. Transforming patient lives through science.
#News #Interview #RareDisease #Hemophilia #Immunoscience
#News #Interview #RareDisease #Hemophilia #Immunoscience
Sanofi’s ASH 2025: Redefining rare blood disorder care
Sanofi’s head of rare diseases, Jeff Schaffnit, outlines the company's dual approach: redefining hemophilia care and pioneering immune modulation for rare blood disorders.
druganddeviceworld.com
December 10, 2025 at 11:57 AM
Sanofi’s #ASH25 data highlight leadership in rare blood diseases, from multi-immune modulation with #BTKinhibitor Wayrilz to long-term hemophilia care with ALTUVIIIO. Transforming patient lives through science.
#News #Interview #RareDisease #Hemophilia #Immunoscience
#News #Interview #RareDisease #Hemophilia #Immunoscience
Sanofi’s #ASH25 data highlight leadership in rare blood diseases, from multi-immune modulation with #BTKinhibitor Wayrilz to long-term hemophilia care with ALTUVIIIO. Transforming patient lives through science.
#News #Interview #RareDisease #Hemophilia #Immunoscience
#News #Interview #RareDisease #Hemophilia #Immunoscience
Sanofi’s ASH 2025: Redefining rare blood disorder care
Sanofi’s head of rare diseases, Jeff Schaffnit, outlines the company's dual approach: redefining hemophilia care and pioneering immune modulation for rare blood disorders.
druganddeviceworld.com
December 10, 2025 at 11:57 AM
Sanofi’s #ASH25 data highlight leadership in rare blood diseases, from multi-immune modulation with #BTKinhibitor Wayrilz to long-term hemophilia care with ALTUVIIIO. Transforming patient lives through science.
#News #Interview #RareDisease #Hemophilia #Immunoscience
#News #Interview #RareDisease #Hemophilia #Immunoscience
BioNTech names Guido Oelkers, Ph.D., ex-Sobi CEO, as new CEO after six-month search. Oelkers led $915M Dova Pharmaceuticals acquisition and launched Altuviiio bleeding disorder drug with Sanofi. BioNTech poised for strategic growth with new leadership.
August 9, 2026 at 8:04 PM
BioNTech names Guido Oelkers, Ph.D., ex-Sobi CEO, as new CEO after six-month search. Oelkers led $915M Dova Pharmaceuticals acquisition and launched Altuviiio bleeding disorder drug with Sanofi. BioNTech poised for strategic growth with new leadership.
Director, Global Marketing- Hemophilia A (ALTUVIIIO) - Cambridge Job educativ.net/jobs/job/43943...
August 28, 2025 at 8:47 AM
Director, Global Marketing- Hemophilia A (ALTUVIIIO) - Cambridge Job educativ.net/jobs/job/43943...
Director, Global Marketing- Hemophilia A (ALTUVIIIO) - Cambridge Job educativ.net/jobs/job/43943...
August 28, 2025 at 7:37 AM
Director, Global Marketing- Hemophilia A (ALTUVIIIO) - Cambridge Job educativ.net/jobs/job/43943...
Director, Global Marketing- Hemophilia A (ALTUVIIIO) - Cambridge Job educativ.net/jobs/job/43943...
August 28, 2025 at 6:30 AM
Director, Global Marketing- Hemophilia A (ALTUVIIIO) - Cambridge Job educativ.net/jobs/job/43943...
Director, Global Marketing- Hemophilia A (ALTUVIIIO) - Cambridge Job educativ.net/jobs/job/43943...
August 28, 2025 at 4:11 AM
Director, Global Marketing- Hemophilia A (ALTUVIIIO) - Cambridge Job educativ.net/jobs/job/43943...
Director, Global Marketing- Hemophilia A (ALTUVIIIO) - Cambridge Job educativ.net/jobs/job/43943...
August 28, 2025 at 3:48 AM
Director, Global Marketing- Hemophilia A (ALTUVIIIO) - Cambridge Job educativ.net/jobs/job/43943...
Associate Director, Global Marketing, Hemophilia A (ALTUVIIIO & ELOCTATE) - Cambridge Job educativ.net/jobs/job/43074...
August 13, 2025 at 6:47 AM
Associate Director, Global Marketing, Hemophilia A (ALTUVIIIO & ELOCTATE) - Cambridge Job educativ.net/jobs/job/43074...
Associate Director, Global Marketing, Hemophilia A (ALTUVIIIO & ELOCTATE) - Cambridge Job educativ.net/jobs/job/43074...
August 13, 2025 at 4:09 AM
Associate Director, Global Marketing, Hemophilia A (ALTUVIIIO & ELOCTATE) - Cambridge Job educativ.net/jobs/job/43074...
Associate Director, Global Marketing, Hemophilia A (ALTUVIIIO & ELOCTATE) - Cambridge Job educativ.net/jobs/job/43074...
August 13, 2025 at 3:01 AM
Associate Director, Global Marketing, Hemophilia A (ALTUVIIIO & ELOCTATE) - Cambridge Job educativ.net/jobs/job/43074...
Associate Director, Global Marketing, Hemophilia A (ALTUVIIIO & ELOCTATE) - Cambridge Job educativ.net/jobs/job/43074...
August 13, 2025 at 2:32 AM
Associate Director, Global Marketing, Hemophilia A (ALTUVIIIO & ELOCTATE) - Cambridge Job educativ.net/jobs/job/43074...
Associate Director, Global Marketing, Hemophilia A (ALTUVIIIO & ELOCTATE) - Cambridge Job educativ.net/jobs/job/43074...
August 13, 2025 at 1:55 AM
Associate Director, Global Marketing, Hemophilia A (ALTUVIIIO & ELOCTATE) - Cambridge Job educativ.net/jobs/job/43074...
Associate Director, Global Marketing, Hemophilia A (ALTUVIIIO & ELOCTATE) - Cambridge Job educativ.net/jobs/job/43074...
August 13, 2025 at 1:20 AM
Associate Director, Global Marketing, Hemophilia A (ALTUVIIIO & ELOCTATE) - Cambridge Job educativ.net/jobs/job/43074...
Director, Global Market Development Lead Hemophilia A (ALTUVIIIO) - Cambridge Job educativ.net/jobs/job/38640...
June 3, 2025 at 7:25 AM
Director, Global Market Development Lead Hemophilia A (ALTUVIIIO) - Cambridge Job educativ.net/jobs/job/38640...
Director, Global Market Development Lead Hemophilia A (ALTUVIIIO) - Cambridge Job educativ.net/jobs/job/38640...
June 3, 2025 at 6:45 AM
Director, Global Market Development Lead Hemophilia A (ALTUVIIIO) - Cambridge Job educativ.net/jobs/job/38640...
Director, Global Market Development Lead Hemophilia A (ALTUVIIIO) - Cambridge Job educativ.net/jobs/job/38640...
June 3, 2025 at 5:03 AM
Director, Global Market Development Lead Hemophilia A (ALTUVIIIO) - Cambridge Job educativ.net/jobs/job/38640...
Director, Global Market Development Lead Hemophilia A (ALTUVIIIO) - Cambridge Job educativ.net/jobs/job/38640...
June 3, 2025 at 4:24 AM
Director, Global Market Development Lead Hemophilia A (ALTUVIIIO) - Cambridge Job educativ.net/jobs/job/38640...
Director, Global Market Development Lead Hemophilia A (ALTUVIIIO) - Cambridge Job educativ.net/jobs/job/38640...
June 3, 2025 at 4:19 AM
Director, Global Market Development Lead Hemophilia A (ALTUVIIIO) - Cambridge Job educativ.net/jobs/job/38640...
Allegedly there's a long-acting VIII product called Altuviiio that you infuse IV. Also gives you some protection against bleeds. I haven't switched yet, partially because I'm a bit lazy and partially because I've been negatively polarized against the med by its dumb fucking name.
March 19, 2026 at 3:11 PM
Allegedly there's a long-acting VIII product called Altuviiio that you infuse IV. Also gives you some protection against bleeds. I haven't switched yet, partially because I'm a bit lazy and partially because I've been negatively polarized against the med by its dumb fucking name.
Sanofi Says Additional ALTUVIIIO Study Analysis Backs Efficacy
June 6, 2025 at 1:15 PM
Sanofi Says Additional ALTUVIIIO Study Analysis Backs Efficacy
Link: http://www.fda.gov/vaccines-blood-biologics/altuviiio
Date: 2025-03-12
Date: 2025-03-12
March 13, 2025 at 5:00 AM
Link: http://www.fda.gov/vaccines-blood-biologics/altuviiio
Date: 2025-03-12
Date: 2025-03-12